Topical Application of Perchlorate: A Toxicity Study in Rats

Author:

Ulloa-Padilla Jan P.12,Burkat Cat N.3,Morgenstern Kenneth E.14

Affiliation:

1. Department of Ophthalmic Plastic and Reconstructive Surgery, Morgenstern Center for Orbital and Facial Plastic Surgery, Wayne

2. Department of Ophthalmic Plastic and Reconstructive Surgery, Wills Eye Hospital, Philadelphia, Pennsylvania

3. Facial Cosmetic & Orbital Surgery, Department of Ophthalmology and Visual Sciences, University of Wisconsin-Madison, Oculoplastic, Madison, Wisconsin

4. Department of Ophthalmic Plastic and Reconstructive Surgery, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, U.S.A.

Abstract

Purpose: To investigate the ocular safety profile of topical perchlorate as a potential preventive treatment for nasolacrimal obstruction associated with excessive use of radioactive iodine therapy. Methods: Nine Wistar male rats (18 eyes) were randomly assigned to receive an ocular application (topical eye drop on the OD, 3 times a day for 5 days) consisting of either: 1) sterile saline solution, 2) 30 mg/ml NaClO4 or 3) 30 mg/ml KClO4. The rat eyes were examined daily for corneal cloudiness/clarity, discharge, mucous secretions, conjunctival injection, eyelid erythema, and/or changes in behavior. Seven days after the first dose, the rats were euthanized and OU were harvested, fixed, embedded in paraffin, and stained with H&E and Masson’s trichrome using standard techniques. Results: The data collected over the 7 days revealed no behavior changes or ocular complications in any of the 3 study groups. Pathologic analysis of the corneas revealed normal findings on all groups without signs of inflammation, fibrosis, or any other abnormality, and no difference between the treated and control eyes. Conclusions: The findings of this study suggest that the use of topical perchlorate is safe to use on eyes in high concentrations. The efficacy of this compound in minimizing fibrosis of the nasolacrimal sac and duct warrants further study.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference15 articles.

1. Clinical review 128: Current approaches to primary therapy for papillary and follicular thyroid cancer.;Mazzaferri;J Clin Endocrinol Metab,2001

2. [Radioactive iodine in the treatment of Graves’ disease: history and modern concept of radionuclide therapy].;Sheremeta;Ter Arkh,2022

3. Intermediate and long-term side effects of high-dose radioiodine therapy for thyroid carcinoma.;Alexander;J Nucl Med,1998

4. Salivary and lacrimal gland dysfunction (sicca syndrome) after radioiodine therapy.;Solans;J Nucl Med,2001

5. Expression of sodium iodide symporter in the lacrimal drainage system: implication for the mechanism underlying nasolacrimal duct obstruction in I(131)-treated patients.;Morgenstern;Ophthalmic Plast Reconstr Surg,2005

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3